Thieno[2,3-d]pyrimidines in the synthesis of antitumor and antioxidant agents

Arch Pharm (Weinheim). 2010 May;343(5):301-9. doi: 10.1002/ardp.200900245.

Abstract

Dimethyl acetylenedicarboxylate, ethyl propiolate, and E-dibenzoylethylene react with thienopyrimidines (cyclo-pentyl, -hexyl, and -heptyl) derivatives to form thiazolo[3,2-a]thieno-[2,3-d]pyrimidin-2-ylidene) acetates, thieno[2,3-d]pyrimidin-2-ylthioacrylates, and thieno[2',3':4,5]pyrimido[2,1-b][1,3]thiazin-6-ones, respectively. Reactions proceed via cyclization and thio-addition processes. Some derivatives of thienopyrimidines showed high inhibition of Hep-G2 cell growth compared with the growth of untreated control cells. However, the fused heptyl of thienopyrimidothiazines indicates a promising specific antitumor agent against Hep-G2 cells with IC(50 )< 20 microM.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Antioxidants / chemical synthesis*
  • Antioxidants / pharmacology*
  • Biphenyl Compounds / antagonists & inhibitors
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cyclization
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Drug Screening Assays, Antitumor / methods
  • HCT116 Cells
  • Hep G2 Cells
  • Humans
  • Picrates / antagonists & inhibitors
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Biphenyl Compounds
  • Picrates
  • Pyrimidines
  • thienopyrimidine
  • 1,1-diphenyl-2-picrylhydrazyl